K Kiuchi1, J Nejima, T Takano, M Ohta, H Hashimoto. 1. Intensive and Coronary Care Unit and the First Department of Internal Medicine, Nippon Medical School, Tokyo 113-8603, Japan.
Abstract
OBJECTIVE: To assess whether the concentrations of serum advanced glycation end products (AGE) in diabetic patients with obstructive coronary artery disease differ from those in type 2 diabetic patients without obstructive coronary artery disease. DESIGN: Serum AGE concentrations were measured in type 2 diabetic patients and in non-diabetic patients, both with and without obstructive coronary artery disease, and the relation between these values and coronary disease severity was evaluated. RESULTS: Mean (SD) serum AGE concentrations were higher (p < 0.0125) in type 2 diabetic patients with obstructive coronary artery disease (5.5 (2.5) mU/ml, n = 30) than in patients without obstructive coronary artery disease (2.8 (0. 5) mU/ml, n = 12), and higher than in non-diabetic patients with (3. 4 (1.0) mU/ml, n = 28) and without (3.2 (0.4) mU/ml, n = 13) obstructive coronary artery disease. Serum AGE was associated with the degree of coronary arteriosclerosis in type 2 diabetic patients with obstructive coronary artery disease (single vessel: n = 13, 3.4 (0.9) mU/m; two vessel: n = 6, 5.7 (1.6) mU/m; three vessel: n = 11, 7.2 (2.5) mU/ml). Serum AGE was positively correlated with serum mean four year HbA(1C) (r = 0.46, p < 0.01), but not with recent serum HbA(1C) (r = 0.24). The four groups did not differ in the other coronary risk factors. CONCLUSIONS: Serum AGE concentrations may be associated with long term poor glycaemic control and reflect the severity of coronary arteriosclerosis in type 2 diabetic patients.
OBJECTIVE: To assess whether the concentrations of serum advanced glycation end products (AGE) in diabeticpatients with obstructive coronary artery disease differ from those in type 2 diabeticpatients without obstructive coronary artery disease. DESIGN: Serum AGE concentrations were measured in type 2 diabeticpatients and in non-diabeticpatients, both with and without obstructive coronary artery disease, and the relation between these values and coronary disease severity was evaluated. RESULTS: Mean (SD) serum AGE concentrations were higher (p < 0.0125) in type 2 diabeticpatients with obstructive coronary artery disease (5.5 (2.5) mU/ml, n = 30) than in patients without obstructive coronary artery disease (2.8 (0. 5) mU/ml, n = 12), and higher than in non-diabeticpatients with (3. 4 (1.0) mU/ml, n = 28) and without (3.2 (0.4) mU/ml, n = 13) obstructive coronary artery disease. Serum AGE was associated with the degree of coronary arteriosclerosis in type 2 diabeticpatients with obstructive coronary artery disease (single vessel: n = 13, 3.4 (0.9) mU/m; two vessel: n = 6, 5.7 (1.6) mU/m; three vessel: n = 11, 7.2 (2.5) mU/ml). Serum AGE was positively correlated with serum mean four year HbA(1C) (r = 0.46, p < 0.01), but not with recent serum HbA(1C) (r = 0.24). The four groups did not differ in the other coronary risk factors. CONCLUSIONS: Serum AGE concentrations may be associated with long term poor glycaemic control and reflect the severity of coronary arteriosclerosis in type 2 diabeticpatients.
Authors: H Nakayama; S Taneda; S Kuwajima; S Aoki; Y Kuroda; K Misawa; S Nakagawa Journal: Biochem Biophys Res Commun Date: 1989-07-31 Impact factor: 3.575
Authors: Z Makita; S Radoff; E J Rayfield; Z Yang; E Skolnik; V Delaney; E A Friedman; A Cerami; H Vlassara Journal: N Engl J Med Date: 1991-09-19 Impact factor: 91.245
Authors: Peter Celec; Július Hodosy; Peter Jáni; Pavol Janega; Matúš Kúdela; Marta Kalousová; Johana Holzerová; Vojtech Parrák; Lukáč Halčák; Tomáš Zima; Martin Braun; Ivan Pecháň; Ján Murín; Katarína Šebeková Journal: Heart Vessels Date: 2011-05-12 Impact factor: 2.037
Authors: Anand Prasad; James R Lane; Sotirios Tsimikas; Ehtisham Mahmud; Srikrishna Khandrika; Peter Bekker; Manjusha Ilapakurti; Dan Nguyen; Amir Ravandi; Travis Israel Journal: Int J Angiol Date: 2015-03-23
Authors: B K Kilhovd; A Juutilainen; S Lehto; T Rönnemaa; P A Torjesen; K F Hanssen; M Laakso Journal: Diabetologia Date: 2007-05-04 Impact factor: 10.122
Authors: R Meerwaldt; R Graaff; P H N Oomen; T P Links; J J Jager; N L Alderson; S R Thorpe; J W Baynes; R O B Gans; A J Smit Journal: Diabetologia Date: 2004-07-09 Impact factor: 10.122
Authors: Marcus Baumann; Tom Richart; Daniel Sollinger; Jaroslav Pelisek; Marcel Roos; Tatiana Kouznetsova; Hans-Henning Eckstein; Uwe Heemann; Jan A Staessen Journal: Cardiovasc Diabetol Date: 2009-08-06 Impact factor: 9.951
Authors: N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit Journal: J Inherit Metab Dis Date: 2007-06-14 Impact factor: 4.982